About Szpital Specjalistyczny nr 1 w Bytomiu
Clinical Trials at Szpital Specjalistyczny nr 1 w Bytomiu
During the past decade, Szpital Specjalistyczny nr 1 w Bytomiu conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 5 clinical trials were completed, i.e. on
average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Szpital Specjalistyczny nr 1 w Bytomiu" #1 sponsor was "Shire" with 2 trials, followed by "Allergan" with 1 trials
sponsored, "Calliditas Therapeutics Suisse SA" with 1 trials sponsored, "Pfizer" with 1 trials sponsored and "Quark Pharmaceuticals"
with 1 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Szpital Specjalistyczny nr 1 w Bytomiu"
#1 collaborator was "OCT Clinical Trials" with 1 trials as a collaborator and "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Szpital Specjalistyczny nr 1 w Bytomiu
According to Clinical.Site data, the most researched conditions in "Szpital Specjalistyczny nr 1 w Bytomiu" are
"Rheumatoid Arthritis" (3 trials), "Adenoviral Conjunctivitis" (1 trials), "Bacterial Conjunctivitis" (1 trials), "Choroidal Neovascularization" (1 trials) and "Diabetic Macular Edema" (1 trials). Many other conditions were trialed in "Szpital Specjalistyczny nr 1 w Bytomiu" in a lesser frequency.
Clinical Trials Intervention Types at Szpital Specjalistyczny nr 1 w Bytomiu
Most popular intervention types in "Szpital Specjalistyczny nr 1 w Bytomiu" are "Drug" (8 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "PVP-I 0.6%" (2 trials), "SHP640" (2 trials), "AGN-195263" (1 trials) and "Adalimumab 40mg q2w" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Szpital Specjalistyczny nr 1 w Bytomiu
The vast majority of trials in "Szpital Specjalistyczny nr 1 w Bytomiu" are
8 trials for "All" genders.
Clinical Trials Status at Szpital Specjalistyczny nr 1 w Bytomiu
Currently, there are NaN active trials in "Szpital Specjalistyczny nr 1 w Bytomiu".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Szpital Specjalistyczny nr 1 w Bytomiu,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Szpital Specjalistyczny nr 1 w Bytomiu, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".
Departments of Szpital Specjalistyczny nr 1 w Bytomiu
Szpital Specjalistyczny nr 1 w Bytomiu has several departments that took part in Clinical trials: "Szpital Specjalistyczny Nr 1 w Bytomiu, Oddzial Obserwacyjno-Zakazny i Hepatologii" - 2 trials, "Szpital Specjalistyczny Nr 1; Oddzial Reumatologii I Rehabilitacji" - 2 trials